Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwen Liu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Advances in Medical Oncology|September 30, 2024
Comparison of neoadjuvant chemotherapy response and prognosis among pegylated liposomal doxorubicin, epirubicin and pirarubicin in HR ⩽ 10%/HER2-negative breast cancer: an exploratory real-world multicentre cohort studyYue Hong, Jing Peng, Qitong Chen, et al.
International Journal of Surgery (London, England)|January 28, 2026
Long-term outcomes of ureteral replacement and epithelial regeneration with tapered demucosalized ileumShulian Chen, Wen Tang, Huihui Xie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Intravenous Administration of EXG110 Resulted in Substrate Correction in Fabry Mice and Sustained Enzyme Activity in Non-human PrimatesShaoyong Li, Pengfei Yu, Hong Wang, et al.
Eclinicalmedicine|July 7, 2025
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter studyLimeng Qu, Jinfeng Zhu, Xilong Mei, et al.
Annals of Translational Medicine|January 20, 2023
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort studyMeirong Zhou, Shouman Wang, Nengbin Wan, et al.
Therapeutic Advances in Medical Oncology|November 3, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world studyJing Peng, Qitong Chen, Liping Liu, et al.
Frontiers in Oncology|March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology|June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter DataMunawar Anwar, Qitong Chen, Dengjie Ouyang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Advances in Medical Oncology|September 30, 2024
Comparison of neoadjuvant chemotherapy response and prognosis among pegylated liposomal doxorubicin, epirubicin and pirarubicin in HR ⩽ 10%/HER2-negative breast cancer: an exploratory real-world multicentre cohort studyYue Hong, Jing Peng, Qitong Chen, et al.
International Journal of Surgery (London, England)|January 28, 2026
Long-term outcomes of ureteral replacement and epithelial regeneration with tapered demucosalized ileumShulian Chen, Wen Tang, Huihui Xie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Intravenous Administration of EXG110 Resulted in Substrate Correction in Fabry Mice and Sustained Enzyme Activity in Non-human PrimatesShaoyong Li, Pengfei Yu, Hong Wang, et al.
Eclinicalmedicine|July 7, 2025
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter studyLimeng Qu, Jinfeng Zhu, Xilong Mei, et al.
Annals of Translational Medicine|January 20, 2023
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort studyMeirong Zhou, Shouman Wang, Nengbin Wan, et al.
Therapeutic Advances in Medical Oncology|November 3, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world studyJing Peng, Qitong Chen, Liping Liu, et al.
Frontiers in Oncology|March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology|June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter DataMunawar Anwar, Qitong Chen, Dengjie Ouyang, et al.
Pageof 3